The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: Possible involvement of the ERK1/2-JunB pathway

Biochemical and Biophysical Research Communications

Volumn 374, Issue 2, 2008, Pages 351-355

  Cevik, Muhammer Ozgur ^a   Katsuyama, Masato ^a   Kanda, Sayaka ^a   Kaneko, Tetsuo ^b   Iwata, Kazumi ^a   Ibi, Masakazu ^a   Matsuno, Kuniharu ^a   Kakehi, Tomoko ^a   Cui, Wenhao ^a   Sasaki, Mika ^a   Yabe Nishimura, Chihiro ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

ERK1 2; JunB; NADPH oxidase; NOX1; Vascular smooth muscle cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN F2 ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SUPEROXIDE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB;

ANIMAL CELL; AORTA MEDIA; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ASSAY; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; GENETIC ANALYSIS; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; TRANSCRIPTION INITIATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CONSENSUS SEQUENCE; DINOPROST; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MUTATION; NADH, NADPH OXIDOREDUCTASES; PROMOTER REGIONS (GENETICS); PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; SUPEROXIDES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 48349103018     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.027     Document Type: Article

References (21)

1. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86 (2000) 494-501
2. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87 (2000) 179-183
3. Guzik T.J., West N.E., Black E., McDonald D., Ratnatunga C., Pillai R., and Channon K.M. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ. Res. 86 (2000) E85-E90
4. Lambeth J.D., Kawahara T., and Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic. Biol. Med. 43 (2007) 319-331
5. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A.B., Griendling K.K., and Lambeth J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401 (1999) 79-82
6. Banfi B., Maturana A., Jaconi S., Arnaudeau S., Laforge T., Sinha B., Ligeti E., Demaurex N., and Krause K.H. A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science 287 (2000) 138-142
7. Lassegue B., Sorescu D., Szocs K., Yin Q., Akers M., Zhang Y., Grant S.L., Lambeth J.D., and Griendling K.K. Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88 (2001) 888-894
8. Katsuyama M., Fan C., and Yabe-Nishimura C. NADPH oxidase is involved in prostaglandin F2alpha-induced hypertrophy of vascular smooth muscle cells: induction of NOX1 by PGF2alpha. J. Biol. Chem. 277 (2002) 13438-13442
9. Fan C., Kawai Y., Inaba S., Arakawa K., Katsuyama M., Kajinami K., Yasuda T., Yabe-Nishimura C., Konoshita T., and Miyamori I. Synergy of aldosterone and high salt induces vascular smooth muscle hypertrophy through up-regulation of NOX1. J. Steroid Biochem. Mol. Biol. (2008)
10. Arakawa N., Katsuyama M., Matsuno K., Urao N., Tabuchi Y., Okigaki M., Matsubara H., and Yabe-Nishimura C. Novel transcripts of Nox1 are regulated by alternative promoters and expressed under phenotypic modulation of vascular smooth muscle cells. Biochem. J. 398 (2006) 303-310
11. Fan C., Katsuyama M., Nishinaka T., and Yabe-Nishimura C. Transactivation of the EGF receptor and a PI3 kinase-ATF-1 pathway is involved in the upregulation of NOX1, a catalytic subunit of NADPH oxidase. FEBS Lett. 579 (2005) 1301-1305
12. Fan C., Katsuyama M., and Yabe-Nishimura C. PKCdelta mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: possible involvement of PKCdelta in vascular hypertrophy. Biochem. J. 390 (2005) 761-767
13. Katsuyama M., Fan C., Arakawa N., Nishinaka T., Miyagishi M., Taira K., and Yabe-Nishimura C. Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: involvement of mitochondrial respiratory chain. Biochem. J. 386 (2005) 255-261
14. Katsuyama M., Cevik M.O., Arakawa N., Kakehi T., Nishinaka T., Iwata K., Ibi M., Matsuno K., and Yabe-Nishimura C. Myocyte enhancer factor 2B is involved in the inducible expression of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme. FEBS J. 274 (2007) 5128-5136
15. Nishinaka T., Fu Y.H., Chen L.I., Yokoyama K., and Chiu R. A unique cathepsin-like protease isolated from CV-1 cells is involved in rapid degradation of retinoblastoma susceptibility gene product, RB, and transcription factor SP1. Biochim. Biophys. Acta 1351 (1997) 274-286
16. Rao G.N., Katki K.A., Madamanchi N.R., Wu Y., and Birrer M.J. JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells. J. Biol. Chem. 274 (1999) 6003-6010
17. Rose P., Bond J., Tighe S., Toth M.J., Wellman T.L., de Montiano E.M., Lewinter M.M., and Lounsbury K.M. Genes overexpressed in cerebral arteries following salt-induced hypertensive disease are regulated by angiotensin II, JunB, and CREB. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H1075-H1085
18. Matsuno K., Yamada H., Iwata K., Jin D., Katsuyama M., Matsuki M., Takai S., Yamanishi K., Miyazaki M., Matsubara H., and Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112 (2005) 2677-2685
19. Manea A., Manea S.A., Gafencu A.V., Raicu M., and Simionescu M. AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 878-885
20. Banfi B., Molnar G., Maturana A., Steger K., Hegedus B., Demaurex N., and Krause K.H. A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J. Biol. Chem. 276 (2001) 37594-37601
21. Jay D.B., Papaharalambus C.A., Seidel-Rogol B., Dikalova A.E., Lassegue B., and Griendling K.K. Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells. Free Radic. Biol. Med. 45 (2008) 329-335